Lawsuit for Investors in Shares of Seattle Genetics, Inc. (NASDAQ:SGEN) over Alleged Misleading Statements
An investor, who purchased shares of Seattle Genetics, Inc. (NASDAQ:SGEN), filed a lawsuit in Washington over alleged Securities Laws violations by Seattle Genetics, Inc. in connection with certain allegedly false and misleading statements.
View full press release